In sport, doping refers to the use of prohibited substances or methods to enhance performance beyond what would ordinarily be achieved through training and natural ability. But what happens when the performance-enhancing substance is money?
That is the idea behind financial
doping.
The term is most commonly used in
sports economics, particularly football, to describe situations where clubs use
unusually large injections of external finance – often from wealthy owners,
lenders or related parties – to spend beyond what their underlying operating
revenues would ordinarily support. Academic research has explicitly examined
the concept in the English Premier League and its relationship with competitive
advantage. (Taylor
& Francis Online)
However, the underlying economic
phenomenon extends beyond football. In broader financial and corporate
contexts, similar dynamics can arise when cheap credit, government subsidies,
guarantees or continuing financial support allow economically weak organisations
to survive and compete against organisations operating without comparable
assistance.
The fundamental question is
therefore:
When does financial support
become a legitimate investment, and when does it become an artificial
performance enhancer?
1. What Exactly Is Financial
Doping?
Financial doping can be
understood as the use of exceptional, subsidised, external or artificially
structured financial resources to enhance competitive performance beyond what
an organisation's underlying operating capacity would normally permit.
Consider two football clubs.
Club A generates £300
million of sustainable annual revenue and spends £250 million on players and
wages.
Club B generates only £100
million but receives substantial owner funding and loans, allowing it to spend
£250 million as well.
On the surface, both clubs may be
spending £250 million. Economically, however, they are not operating from the
same financial base. Club B has effectively obtained an additional source of
competitive capacity. This does not automatically mean that Club B has done
anything illegal. Investment is not the same as doping. An owner
investing capital in a business may be entirely legitimate.
The concern arises when financial
resources:
- circumvent applicable financial restrictions;
- conceal the true economic position of the
organisation;
- allow persistent spending unrelated to sustainable
revenue;
- keep fundamentally unviable businesses alive;
- distort competition;
- or create advantages unavailable to competitors
operating under normal market constraints.
2. Financial Doping Is Not
Simply “Having More Money”
This distinction is important. A
company with £10 billion in revenue is not necessarily financially doping
simply because it can spend more than a company with £100 million in revenue. Similarly,
an entrepreneur investing personal capital into a start-up is not automatically
engaging in financial doping.
Competitive advantage arising
from genuine productivity, innovation, investment or superior business
performance is a normal feature of capitalism. Financial doping becomes
problematic when the source or structure of finance artificially disconnects
competitive spending from sustainable economic capacity or regulatory
constraints. This distinction is particularly important in professional
sport.
Research on the English Premier
League found evidence that money and investment can translate into sporting
performance, raising questions about the competitive consequences of large
financial injections. The researchers examined the relationship between
financial investment and sporting success and argued that regulation is
necessary to address potential distortions. (Taylor
& Francis Online)
3. The Football Laboratory:
Financial Doping in the Premier League
Football provides perhaps the
clearest real-world laboratory for understanding financial doping.
Before UEFA and domestic
financial regulations became more restrictive, some clubs could use loans from
owners and banks to finance player acquisitions and wage expenditure at levels
that their operating revenues could not independently support.
A 2024 empirical study of English
Premier League clubs found that, before Financial Fair Play restrictions, the
amount clubs spent on player acquisitions could exceed what their revenues
could fund, with the difference being covered through bank and owner financing.
The authors explicitly describe this phenomenon as “financial doping.” (DOI)
This creates an important
economic mechanism: External finance → greater spending capacity → stronger
squad → improved sporting performance → potentially higher revenues.
And this can become
self-reinforcing.
·
A club spends heavily.
·
It attracts better players.
·
It performs better.
·
It qualifies for lucrative competitions.
·
It attracts more supporters and sponsors.
·
Its revenues increase.
·
It then has even greater capacity to spend.
This creates what economists
might describe as a feedback loop between financial capacity and competitive
performance.
4. Manchester City: A
Contemporary Case Study
The debate over Manchester City
illustrates why financial doping remains such a controversial concept.
In September 2026, an independent
Premier League commission found Manchester City guilty of breaching financial
regulations, following allegations concerning commercial revenues and
related-party funding. Reuters reported that the commission found that sham
commercial contracts had been used to disguise £831 million of equity funding
as sponsorship income over a nine-year period ending in 2018. Manchester City
has denied the findings and said it intends to appeal. (Reuters)
The case is particularly
important because the alleged mechanism is not simply: “A wealthy owner
spent money.” The much more fundamental issue is whether money was presented
as something economically different from what it actually was. That
distinction goes to the heart of financial regulation.
If equity funding is presented as
commercial revenue, the reported financial capacity of the organisation can
appear stronger than its underlying economics.
That can potentially affect:
- expenditure limits;
- player recruitment;
- wage commitments;
- regulatory compliance;
- competitive balance.
It is therefore useful to
distinguish between financial capacity and financial presentation.
A club may have substantial financial backing. That is one thing. But if the
source or nature of that backing is misrepresented to circumvent financial
controls, that is an entirely different issue.
Manchester City has disputed the
commission's findings, so the case should be understood as a contested
regulatory matter subject to appeal rather than as an uncontested factual
account of wrongdoing. (Reuters)
5. Financial Doping Does Not
Belong Only to Football
The concept becomes even more
interesting when we move from football to the wider economy. Imagine a
manufacturing company that consistently makes losses. It cannot generate enough
operating cash to service its debt. Yet banks continue lending to it at
unusually favourable rates. Government subsidies keep arriving. Its creditors
continue rolling over existing loans. Instead of restructuring or exiting the
market, the company continues operating. This company may become what
economists call a zombie firm.
The World Bank defines non-viable
zombie firms as firms generating enough income to service interest but not
enough to repay their outstanding debt. Such firms can absorb resources that
could otherwise be deployed by more productive businesses. (World Bank)
This is not necessarily fraud. It
is a different economic problem:
Financial support can
sometimes keep an economically weak organisation alive long after the market
would otherwise have forced restructuring or exit.
That is one of the broader
economic parallels with financial doping.
6. Empirical Evidence: Zombie
Firms Around the World
This is not merely theoretical. A
large international study covering firms across 79 countries between 2005
and 2016 found that zombie firms represented roughly 10% of the
observations in its dataset. The research also found that stronger
debt-enforcement environments were associated with fewer zombie firms. (ScienceDirect)
This matters because capital is
not unlimited. If £1 million is committed to an inefficient company that is
being kept alive artificially, that £1 million cannot simultaneously be used by
another company with a potentially higher return. The issue is therefore not
simply: “Is the weak company receiving money?” And the deeper question
is:
“What is the opportunity cost
of keeping that company alive?”
7. China Provides Another
Empirical Example
Research using firm-level
manufacturing data in China provides further evidence.
A 2025 study published in Economica
examined zombie firms and state subsidies. The researchers found that zombie
firms were, on average, larger and less productive than non-zombie firms and
received higher subsidy rates. Their modelling suggested that reducing subsidy
dispersion and facilitating the exit of zombie firms could reduce zombie
activity and improve aggregate productivity. (Wiley
Online Library)
This is a fascinating finding. A
subsidy can have a perfectly legitimate economic purpose. Governments may
subsidise businesses to:
- encourage innovation;
- protect employment;
- develop strategic industries;
- support investment;
- address market failures;
- stimulate regional development.
The problem arises when financial
support becomes disconnected from productivity. At that point, the subsidy may
stop being a bridge to competitiveness and become a life-support
mechanism for inefficiency.
8. The Moral Hazard Problem
Financial doping creates an important concept in economics: Moral hazard. If an organisation knows that someone else will continually absorb the consequences of its financial decisions, its incentives can change. Consider two businesses.
Business A
The owner knows: “If I make a bad
investment, I bear the loss.” The owner therefore has a strong incentive to
assess:
- return on investment;
- cash flow;
- risk;
- productivity;
- cost control.
Business B
Management believes: “If things
go wrong, the owner will inject more money.”
Or: “The government will
subsidise us.”
Or: “The bank will simply roll
over the debt.”
The incentive to impose financial
discipline may weaken.
Research on Chinese industrial
firms found that moral hazard associated with financial instability made
subsidies less effective in improving efficiency and profitability among zombie
firms. (ScienceDirect)
This is why financial doping can
create a dangerous cycle:
Poor performance → financial
support → reduced pressure to restructure → continued poor performance →
further financial support.
9. Financial Doping Can Punish
Efficient Competitors
This may be the most important
economic consequence. Imagine two companies competing in the same market.
Company A
- controls costs;
- invests carefully;
- manages working capital;
- pays market interest rates;
- restructures when necessary;
- exits unprofitable markets.
Company B
- receives subsidised finance;
- enjoys government support;
- has access to cheap related-party funding;
- continues loss-making operations.
Company B may now sell products
at prices that Company A cannot sustainably match.
The result can be resource
misallocation. Research on zombie firms has found evidence that zombie
firms can negatively affect the operating efficiency of normal firms and
increase their debt-financing costs. (DOI)
In other words: Financial
support for one inefficient organisation can impose costs on organisations that
are financially healthy. This is why financial doping is ultimately a
competition issue.
10. Financial Doping Can
Create the Illusion of Success
There is another dimension that
deserves attention. Money can sometimes conceal underlying weaknesses. A
company can appear successful because it has:
- abundant funding;
- aggressive acquisition programmes;
- rapid expansion;
- expensive marketing;
- large offices;
- high employee numbers;
- impressive technology;
- substantial assets.
But these indicators do not
necessarily mean the business model is economically sustainable.
The critical questions are:
·
Is the organisation generating sustainable
operating cash flow?
·
Is capital being allocated efficiently?
·
Can it survive without exceptional external
support?
·
Are returns on capital adequate?
·
Is growth being financed by genuine earnings
or by continually increasing leverage?
These questions move the
discussion from appearance to economic substance.
11. Financial Doping Is
Different from Financial Engineering
This distinction is particularly
important for finance professionals. Not every sophisticated financial
structure constitutes financial doping.
Businesses legitimately use:
- debt financing;
- equity financing;
- leasing;
- securitisation;
- derivatives;
- tax planning;
- working-capital facilities;
- project finance;
- private equity;
- venture capital.
These are ordinary instruments of
modern finance. The concern begins when financial engineering is used to misrepresent
economic reality, circumvent legitimate restrictions, or sustain an otherwise
unviable competitive position. Therefore: Financial innovation creates
value when it improves the allocation of capital. Financial doping creates
distortion when it obscures or artificially enhances economic capacity.
12. The Procurement and
Supply-Chain Dimension
Financial doping also has
implications for procurement and supply-chain management.
Suppose Supplier A has:
- strong cash flow;
- healthy working capital;
- sustainable margins;
- efficient production.
Supplier B has:
- weak cash flow;
- high debt;
- recurring losses;
- but substantial external financial support.
Supplier B may offer
extraordinarily low prices simply because its financial backers are effectively
subsidising its operations. A procurement team focusing only on purchase
price might select Supplier B. But a robust procurement process should
consider Total Cost of Ownership (TCO) and supplier financial
resilience. Why?
Because the apparent saving may
disappear if the supplier subsequently:
- fails to deliver;
- enters insolvency;
- reduces quality;
- cannot fund inventory;
- suffers production disruption;
- requests price increases;
- or defaults on contractual obligations.
Thus, financial doping can become
a supplier-risk issue. The cheapest supplier is not necessarily the
lowest-cost supplier.
13. The Hidden Cost of
Artificially Cheap Capital
One of the most dangerous aspects
of financial doping is that the immediate benefit is visible while the eventual
cost may be hidden.
Immediate benefit:
More money → more spending →
more growth → more market share.
Long-term consequences:
Debt accumulation → resource
misallocation → weaker competitors → distorted prices → financial instability →
eventual restructuring.
The World Bank has highlighted
how non-viable firms can absorb resources that would otherwise be allocated to
healthier businesses, delaying the redeployment of capital to more productive
sectors. (World Bank)
This is why financial doping
should not be assessed solely by asking: “Did the funding create growth?” A
better question is: “Did the funding create sustainable economic value?”
14. Financial Doping Can Be
Self-Reinforcing
One of the most fascinating
characteristics of financial doping is its potential to become a cycle.
Consider this:
Financial support
↓
Greater spending capacity
↓
Better assets / players /
technology / market presence
↓
Improved performance
↓
Higher revenues or market
valuation
↓
Greater borrowing capacity
↓
More financial support
↓
Further expansion
The organisation can therefore
move further and further away from the financial position that its original
operating economics would have produced. This is why financial regulators often
focus not simply on whether money is available, but on where the money comes
from, how it is recognised and whether the resulting economic position is
sustainable.
15. Does Financial Doping
Always Produce Success?
No. This is another important
qualification. Money can buy resources, but resources must still be converted
into performance. An organisation can receive enormous amounts of funding and
still fail because of:
- poor leadership;
- weak governance;
- inefficient procurement;
- bad investment decisions;
- poor talent management;
- corruption;
- weak strategy;
- excessive bureaucracy.
Financial capital is therefore an
enabler, not a guarantee. The empirical football literature nevertheless
finds a relationship between financial investment and sporting performance,
which explains why financial regulation has become such an important issue in
elite sport. (Taylor
& Francis Online)
16. Financial Fair Play: Can
Regulation Stop Financial Doping?
UEFA introduced Financial Fair
Play partly in response to concerns about the financial sustainability of
European football.
Interestingly, empirical research
into the English Premier League found that Financial Fair Play improved clubs'
profitability by encouraging better management of the relationship between
relevant income and expenditure. However, the study did not find
evidence that this improvement necessarily translated into better financial
sustainability, with debt remaining an issue. (DOI)
This illustrates a fundamental
regulatory challenge: Stopping excessive spending is not the same as
creating financial health. A club can comply with one financial metric
while still having:
- significant debt;
- weak cash flow;
- deferred obligations;
- high transfer liabilities;
- structural financial risk.
Regulation therefore has to look
beyond a single ratio.
17. The Bigger Economic Lesson
Financial doping raises a
profound question about capitalism: Should every organisation compete with
whatever financial resources it can obtain, or should markets impose some
boundaries on the way those resources can be used?
There is no simple answer. Investment
is essential to economic development. External finance can:
- create jobs;
- finance innovation;
- accelerate growth;
- build infrastructure;
- rescue strategically important businesses;
- fund new technologies.
But poorly structured financial
support can also:
- preserve inefficiency;
- distort competition;
- encourage excessive risk-taking;
- misallocate capital;
- increase systemic risk.
The objective should therefore
not be to eliminate external finance. It should be to ensure that finance
supports productivity rather than permanently replacing it.
18. Three Questions Every
Business Leader Should Ask
Whether you are running a
football club, manufacturing company, SME or multinational organisation, three
questions are particularly useful.
Question 1: Where is the money
coming from?
Is growth being funded by:
- operating cash flow?
- genuine investment?
- debt?
- subsidies?
- related parties?
- shareholder support?
Question 2: What is the money
producing?
Is additional capital creating:
- productivity?
- innovation?
- sustainable revenue?
- competitive advantage?
- positive cash flow?
Or is it simply covering
recurring losses?
Question 3: What happens when
the money stops?
This may be the most revealing
question of all. If the organisation cannot survive when exceptional funding
disappears, perhaps the funding has been masking rather than solving the
underlying problem.
Conclusion: Money Should Fund
Performance, Not Manufacture It
Financial doping is ultimately
about the relationship between capital and performance.
Money matters. Capital matters. Investment
matters. But sustainable performance requires more than money. It requires productivity,
innovation, governance, discipline, strategy and value creation.
The football evidence
demonstrates how financial resources can influence competitive performance.
Research on zombie firms demonstrates how continued financial support can
preserve inefficient organisations and distort resource allocation. And
contemporary regulatory cases demonstrate the difficulty of determining whether
financial support represents legitimate investment or an attempt to circumvent
financial constraints. (DOI)
The ultimate lesson for business
leaders, investors, regulators and procurement professionals is simple: Capital
should be the fuel for sustainable performance – not a substitute for
it. An organisation that needs exceptional financial oxygen every year may
not have solved its underlying problem. It may simply have become better at buying
time. And that is perhaps the most dangerous form of financial doping: When
money does not make an organisation stronger – it merely makes its
weakness harder to see.
Key empirical evidence at a
glance
|
Area |
Empirical evidence |
What it illustrates |
|
English Premier League |
Research found pre-FFP player
expenditure could be funded through owner and bank loans beyond operating
revenues |
External finance can increase
competitive spending capacity (DOI) |
|
Premier League financial
regulation |
FFP was associated with
improved profitability, although debt/sustainability problems remained |
Profitability and financial
sustainability are not identical (DOI) |
|
Global firms |
Study covering 79 countries
found zombie firms represented roughly 10% of observations |
Zombie firms are a widespread
international phenomenon (ScienceDirect) |
|
Chinese manufacturing |
Zombie firms were found to be
larger, less productive and to receive higher subsidy rates on average |
Subsidies can sometimes sustain
inefficient firms (Wiley
Online Library) |
|
Chinese industrial firms |
Research found moral hazard
made subsidies less effective for zombie firms |
Repeated financial support can
weaken incentives for improvement (ScienceDirect) |
|
Manchester City |
2026 independent commission
found financial-rule breaches involving alleged misrepresentation of equity
funding as sponsorship; City denies the findings and plans to appeal |
The regulatory challenge of
distinguishing genuine commercial revenue from disguised funding (Reuters) |
On a final note, “Financial doping” is not a universally defined accounting or economic offence. In academic literature it is most established as a concept in sports economics. Its use in the wider corporate/economic context is best understood as an analytical extension describing situations where exceptional or subsidised finance artificially sustains or enhances competitive performance. (Taylor & Francis Online)

